PSO vs NYT
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
PSO · Pearson$17.27 ▼ 1.37%
NYT · New York Times$68.36 ▲ 4.26%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- PSO +35.2%
- NYT +10.1%
Head to head
| Metric | PSO | NYT |
|---|---|---|
| Price | $17.27 | $68.36 |
| Change today | ▼ 1.37% | ▲ 4.26% |
| Market cap | $10.38B | $10.93B |
| Return, 3 months | +5.8% | +5.5% |
| Return, year to date | +26.1% | -0.7% |
| Return, 1 year | +35.6% | +12.4% |
| P/E (TTM) | 25.7 | 27.3 |
| P/B | 2.3 | 5.3 |
| P/E percentile vs own 5y | 83rd | 19th |
| Dividend yield | 1.98% | 1.54% |
| Revenue growth (YoY, latest qtr) | +10.3% | +11.2% |
| Net profit growth (YoY) | -2.2% | +12.6% |
| Gross margin | 52.0% | 51.4% |
| Operating margin | 16.9% | 16.6% |
| Net margin | 8.8% | 13.2% |
| Return on equity | 9.2% | 19.7% |
| Analyst target vs. price | +7.1% | +15.6% |
| Analyst buy share | 0% | 71% |
| RSI (14) | 49 | 52 |
| 30-day volatility | 23.5% | 27.7% |
| Max drawdown, 1 year | -18.3% | -27.7% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- NYT is the largest of the group by market value.
- PSO has returned the most over the past year.
- PSO carries the lowest trailing P/E.
- PSO pays the highest dividend yield.
- NYT is growing revenue fastest.
- NYT keeps the most profit per dollar of sales.
- PSO has been the calmest stock over the last 30 days.